Results 21 to 30 of about 23,059 (205)

Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada

Drug and Alcohol Dependence Reports, 2022
Background: Psychedelic-assisted therapies are receiving mounting attention for their therapeutic potential. However, little is known about interest among women who experience elevated risk of mental health and substance use disorders.
Elena Argento, Shira Goldenberg, Kathleen Deering, Jennifer Lavalley, Melissa Braschel, Brittany Bingham, Kate Shannon   +6 more
doaj   +3 more sources

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy

Frontiers in Psychiatry, 2021
Introduction: Psychedelic-assisted psychotherapy is a promising approach in psychiatry; evidence is growing and it may not be long before mainstream services are expected to offer it to selected patients.
Lisa A. Page, Lisa A. Page, Ahmad Rehman, Habib Syed, Kathryn Forcer, Graham Campbell   +5 more
doaj   +2 more sources

Group psychedelic therapy: empirical estimates of cost-savings and improved access

Frontiers in Psychiatry, 2023
ObjectiveTo compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.MethodsUsing 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxymethamphetamine (MDMA) to treat ...
Elliot Marseille, Christopher S. Stauffer, Manish Agrawal, Paul Thambi, Kimberly Roddy, Michael Mithoefer, Stefano M. Bertozzi, James G. Kahn   +7 more
doaj   +3 more sources

Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia [PDF]

Australian and New Zealand Journal of Psychiatry
Objective: Despite rapid advances in psychedelic sciences and the increasing number of countries legalizing psychedelics for the treatment of mental illnesses, the attitudes, knowledge and readiness of both mental health consumers and the general ...
Zohaib Nadeem, Stephen Parker, Lena K L Oestreich   +2 more
exaly   +3 more sources

How to Make Psychedelic-Assisted Therapy Safer

Cambridge Quarterly of Healthcare Ethics
Abstract Classic serotonergic psychedelics are experiencing a clinical revival, which has also revived ethical debates about psychedelic-assisted therapy. A particular issue here is how to prepare and protect patients from the vulnerability that the psychedelic state creates.
Villiger, Daniel; https://orcid.org/, Villiger, Daniel   +1 more
openaire   +5 more sources

Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies. [PDF]

J Relig Health
Abstract The rapid expansion of psychedelic research has opened significant pathways of opportunity in treating mental health disorders. Participants in recent clinical trials consistently report mystical-type experiences during dosing sessions, and some scholars posit that such experiences themselves help mediate clinical ...
Lewis SP, Clark-Soles J, Mayorga O, Sawyer SK, Slavet E, Vidt BJ, Shanti S, Wiggins R, Willis K, Frey J, Grace RM, Cherniak AD.   +11 more
europepmc   +2 more sources

Not a Standalone Treatment: Considerations for Psychedelic‐Assisted Therapy [PDF]

Brain and Behavior
Purpose Psychedelic‐assisted therapy (PAT) is becoming a clinically available treatment for patients with treatment‐resistant conditions such as depression and post‐traumatic stress disorder (PTSD) in several countries.
Sharon Murphy, Elizabeth Stewart, Jacqueline Winship, Laura Kampel, Benjamin Stiel, Justine Ellis   +5 more
doaj   +2 more sources

Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome. [PDF]

J Clin Gastroenterol
Irritable bowel syndrome (IBS) is prevalent and can be disabling. Many patients remain symptomatic despite behavioral and medical therapies. Psychedelic-assisted therapy (PAT), in which serotonergic agents like psilocybin are administered in a psychotherapeutic context, has shown promise for refractory psychiatric disorders, including major depressive ...
Mauney E, King F, Burton-Murray H, Kuo B.   +3 more
europepmc   +4 more sources

Expert recommendations for Germany's integration of psychedelic-assisted therapy. [PDF]

BMC Med Educ
As clinical trials for psychedelics move into phase III in the USA, Europe must address its lag in integrating professional education around psychedelic-assisted therapy (PAT) and supporting psychedelic drug research. This paper evaluates the necessary frameworks for implementing PAT in Germany, emphasizing the nation’s potential leadership role within
Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC.   +5 more
europepmc   +4 more sources

Ensuring Access to Psychedelic-Assisted Therapy in Rural Communities. [PDF]

Psychedelic Med (New Rochelle)
With several classical psychedelics being designated as breakthrough therapies and the recent review of a New Drug Application for 3,4-Methylenedioxymethamphetamine in the treatment of posttraumatic stress disorder, the likelihood of psychedelic medication becoming approved for clinical use in the United States is high.
Dhaliwal OM, Bobak L, Barnett BS.
europepmc   +3 more sources